Potential and challenges for mid-infrared sensors in breath diagnostics

IEEE Sensors Journal

Volumn 10, Issue 1, 2010, Pages 145-158

  Kim, Seong Soo ^a   Young, Christina ^b   Vidakovic, Brani ^b   Gabram Mendola, Sheryl G A ^c   Bayer, Charlene W ^d   Mizaikoff, Boris ^e  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c EMORY UNIVERSITY   (United States)

^d GEORGIA TECH RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF ULM   (Germany)

Author keywords

Absorption spectroscopy; Breast cancer; Chemical sensor; Exhaled breath (EB); Exhaled breath condensate (EBC); Exposure monitoring; Hollow waveguide; Infrared sensor; Mid infrared (MIR); Optical sensor; Planar waveguide; Quantum cascade laser

Indexed keywords

BREAST CANCER; EXHALED BREATH CONDENSATE; EXHALED BREATHS; EXPOSURE MONITORING; HOLLOW WAVEGUIDES; INFRA-RED SENSOR; MIDINFRARED;

ABSORPTION SPECTROSCOPY; CHEMICAL SENSORS; INFRARED DETECTORS; LIGHT SOURCES; OPTICAL SENSORS; PLANAR WAVEGUIDES; QUANTUM CASCADE LASERS; SENSORS;

DIAGNOSIS;

EID: 79952613518     PISSN: 1530437X     EISSN: None     Source Type: Journal    
DOI: 10.1109/JSEN.2009.2033940     Document Type: Article

References (154)

1. J. Huh, D. Yi, and B. Gam, Korea Traditional Medicine Book . Seoul, Korea: Nae Yi Won, 1613.
2. L. Pauling et al., "Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography," in Proc Nat. Acad. Sci. USA, 1971, vol. 68, pp. 2374-2374, 10.
3. M. Phillips, "Method for the collection and assay of volatile organic compounds in breath," Anal. Biochem., vol. 247, no. 2, pp. 272-278, May 1997. (Pubitemid 27200161)
4. M. Phillips et al., "Variation in volatile organic compounds in the breath of normal humans," J. Chromatography B, vol. 729, no. 1-2, pp. 75-88, Jun. 1999. (Pubitemid 29264111)
5. S. A. Kharitonov and P. J. Barnes, "Biomarkers of some pulmonary diseases in exhaled breath," Biomarkers, vol. 7, no. 1, pp. 1-32, Jan.- Feb. 2002.
6. T. H. Risby and S. F. Solga, "Current status of clinical breath analysis," Appl. Phys. B-Lasers Opt., vol. 85, no. 2-3, pp. 421-426, Nov. 2006.
7. C. D. Mansfield, H. H. Mantsch, and H. N. Rutt, "Application of infrared spectroscopy in the measurement of breath trace compounds: A review," Canadian J. Anal. Sci. Spectrosc., vol. 47, no. 1, pp. 14-28, 2002.
8. O. B. Crofford et al., "Acetone in breath and blood," Trans. Amer. Clinical Climatological Assoc., vol. 88, pp. 128-139, 1977.
9. A. W. Jones, "Variability of the blood-breath alcohol ratio invivo," J. Studies on Alcohol, vol. 39, no. 11, pp. 1931-1939, 1978.
10. R. D. Stewart, C. L. Hake, and J. E. Peterson, "Use of breath analysis to monitor trichloroethylene exposures," Archives of Environ. Health, vol. 29, no. 1, pp. 6-13, 1974.
11. K. Nomiyama and H. Nomiyama, "Respiratory retention, uptake and excretion of organic-solvents in man - benzene, toluene, n-hexane, trichloroethylene, acetone, ethyl acetate and ethyl-alcohol," Internationales Archiv Fur Arbeitsmedizin, vol. 32, no. 1-2, pp. 75-83, 1974.
12. G. Rooth and S. Ostenson, "Acetone in alveolar air and control of diabetes," Lancet, vol. 2, no. 7473, pp. 1102-&, 1966.
13. A. M. Lovett et al., "Real-time analysis of breath using an atmospheric-pressure ionization mass-spectrometer," Biomed. Mass Spectrometry, vol. 6, no. 3, pp. 91-97, 1979.
14. M. J. Henderson, B. A. Karger, and G. A. Wrenshall, "Acetone in the breath - A study of acetone exhalation in diabetic and nondiabetic haman subjects," Diabetes, vol. 1, no. 3, pp. 188-&, 1952.
15. M. P. Kalapos, "Possible physiological roles of acetone metabolism in humans," Med. Hypotheses, vol. 53, no. 3, pp. 236-242, Sep. 1999.
16. M. J. Sulway and J. M. Malins, "Acetone in diabetic ketoacidosis," Lancet, vol. 2, no. 7676, pp. 736-&, 1970.
17. D. Y. Graham et al., "Camplobacter-pylori detected noninvasively by the C-13 urea breath test," Lancet, vol. 1, no. 8543, pp. 1174-1177, May 1987.
18. O. Dewit et al., "Starch digestion in young-children with cystic-fibrosis measured using C-13 breath test," Pediatric Res., vol. 32, no. 1, pp. 45-49, Jul. 1992.
19. L. P. Duan et al., "Influence of cisapride on gastric-emptying of solids and liquids monitored by C-13 breath tests," Digestive Diseases and Sci., vol. 40, no. 10, pp. 2200-2206, Oct. 1995.
20. C. Loser et al., "C-13-starch breath test - Comparative clinical evaluation of an indirect pancreatic function test," Zeitschrift Fur Gastroenterologie, vol. 35, no. 3, pp. 187-194, Mar. 1997. (Pubitemid 27163083)
21. W. Kalow and B. K. Tang, "The use of caffeine for enyme assays - A critical-appraisal," Clinical Pharmacology Therapeutics, vol. 53, no. 5, pp. 503-514, May 1993. (Pubitemid 23161197)
22. B. Marshall et al., "Campylobacter pyloridis - A new species of bacteria isolated from the stomach of patients with gastritis and peptic-ulceration," Australian and New Zealand J. Med., vol. 14, no. 6, pp. 906-906, 1984.
23. V. Pasceri et al., "Association of cytotoxin associated gene A Helicobacter pylori with ischemic heart disease," Circulation, vol. 96, no. 8, pp. 174-174, Oct. 1997.
24. D. Forman et al., "An international association between helicobacterpylori infection and gastric-cancer," Lancet, vol. 341, no. 8857, pp. 1359-1362, May 1993.
25. S. A. Kharitonov and P. J. Barnes, "Exhaled biomarkers," Chest, vol. 130, no. 5, pp. 1541-1546, Nov. 2006.
26. J. O. N. Lundberg et al., "Nitric oxide in exhaled air," Eur. Respiratory J., vol. 9, no. 12, pp. 2671-2680, Dec. 1996.
27. S. A. Kharitonov et al., "Increased nitric-oxide in exhaled air of asthmatic-patients," Lancet, vol. 343, no. 8890, pp. 133-135, Jan. 1994.
28. S. A. Kharitonov et al., "Acute and chronic effects of cigarette-smoking on exhaled nitric-oxide," Amer. J. Respiratory Critical Care Med., vol. 152, no. 2, pp. 609-612, Aug. 1995.
29. I. M. BalfourLynn, A. Laverty, and R. Dinwiddie, "Reduced upper airway nitric oxide in cystic fibrosis," Archives of Disease in Childhood, vol. 75, no. 4, pp. 319-322, Oct. 1996.
30. S. R. Thomas et al., "Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype," Chest, vol. 117, no. 4, pp. 1085-1089, Apr. 2000.
31. I. I. Nikberg, V. A. Murashko, and I. N. Leonenko, "Carbon monoxide concentration in the air exhaled by the healthy and the ill," Vrach Delo, vol. 12, pp. 112-114, 1972.
32. K. Zayasu et al., "Increased carbon monoxide in exhaled air of asthmatic patients," Amer. J. Respiratory Critical Care Med., vol. 156, no. 4, pp. 1140-1143, Oct. 1997. (Pubitemid 127702185)
33. W. Biernacki, S. A. Kharitonov, and P. J. Barnes, "Carbon monoxide in exhaled air is elevated in patients with lower respiratory tract infection," Amer. J. Respiratory Critical Care Med., vol. 159, no. 3, pp. A556-A556, Mar. 1999.
34. P. Paredi et al., "Increased carbon monoxide in exhaled air of patients with cystic fibrosis," Thorax, vol. 54, no. 10, pp. 917-920, Oct. 1999. (Pubitemid 29452800)
35. M. Phillips, M. Sabas, and J. Greenberg, "Increased pentane and carbon-disulfide in the breath of patients with schizophrenia," J. Clinical Pathology, vol. 46, no. 9, pp. 861-864, Sep. 1993. (Pubitemid 23287353)
36. M. Phillips et al., "Volatile organic-compounds in the breath of patients with schizophrenia," J. Clinical Pathology, vol. 48, no. 5, pp. 466-469, May 1995.
37. M. Phillips et al., "Volatile markers of breast cancer in the breath," The Breast J., vol. 9, no. 3, pp. 184-191, 2003. (Pubitemid 36627163)
38. M. Phillips et al., "Prediction of breast cancer using volatile biomarkers in the breath," Breast Cancer Res. Treat., vol. 99, no. 1, pp. 19-21, Sep. 2006. (Pubitemid 44168599)
39. M. Phillips et al., "Volatile organic compounds in breath as markers of lung cancer: A cross-sectional study," Lancet, vol. 353, no. 9168, pp. 1930-1933, Jun. 1999. (Pubitemid 29255706)
40. M. Phillips et al., "Detection of lung cancer with volatile markers in the breath," Chest, vol. 123, no. 6, pp. 2115-2123, Jun. 2003. (Pubitemid 36706741)
41. P. Paredi, S. A. Kharitonov, and P. J. Barnes, Anal. Expired Air for Oxidation Products, pp. S31-S37.
42. S. A. Kharitonov and P. J. Barnes, "Exhaled markers of pulmonary disease," Amer. J. Respiratory Critical Care Med., vol. 163, no. 7, pp. 1693-1722, Jun. 2001.
43. P. E. Silkoff et al., "Airway nitric oxide diffusion in asthma - Role in pulmonary function and bronchial responsiveness," Amer. J. Respiratory Critical Care Med., vol. 161, no. 4, pp. 1218-1228, Apr. 2000.
44. S. Tate et al., "Airways in cystic fibrosis are acidified: Detection by exhaled breath condensate," Thorax, vol. 57, no. 11, pp. 926-929, Nov. 2002. (Pubitemid 35316268)
45. C. Gessner et al., "Exhaled breath condensate acidification in acute lung injury," Respiratory Med., vol. 97, no. 11, pp. 1188-1194, Nov. 2003. (Pubitemid 37337014)
46. P. Montuschi, "Exhaled breath condensate analysis in patients with COPD," Clinica Chimica Acta., vol. 356, no. 1-2, pp. 22-34, Jun. 2005. (Pubitemid 40779884)
47. G. E. Carpagnano et al., "Breath condensate pH in children with cystic fibrosis and asthma - A new noninvasive marker of airway inflammation?," Chest, vol. 125, no. 6, pp. 2005-2010, Jun. 2004.
48. G. Vass et al., "Comparison of nasal and oral inhalation during exhaled breath condensate collection," Amer. J. Respiratory Critical Care Med., vol. 167, no. 6, pp. 850-855, Mar. 2003. (Pubitemid 36801772)
49. E. Huszar et al., "Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma," Eur. Respiratory J., vol. 20, no. 6, pp. 1393-1398, Dec. 2002. (Pubitemid 35469046)
50. L. Spicuzza, G. Di Maria, and R. Polosa, "Adenosine in the airways: Implications and applications," Eur. J. Pharmacology, vol. 533, no. 1-3, pp. 77-88, Mar. 2006.
51. F. Bray, P.McCarron, and D. M. Parkin, "The changing global patterns of female breast cancer incidence and mortality," Breast Cancer Res., vol. 6, pp. 229-239, 2004. (Pubitemid 39440251)
52. N. Voyvoda, A. Ozdemir, and S. Gültekin, "Mammography device use in Turkey, and quantity and quality analysis of mammography education," Diagn. Interv. Radiol., vol. 13, pp. 129-133, 2007. (Pubitemid 47354345)
53. P. Boyle, "Breast cancer control: Signs of progress, but more work required," Breast, vol. 14, pp. 429-438, 2005. (Pubitemid 41683563)
54. I. Fleitas, C. Caspani, C. Borrás, M. Plazas, A. Miranda, M. Brandan, and R. de la Mora, "The quality of radiology services in five Latin American countries," Rev. Panam. Salud Publica, vol. 20, pp. 113-124, 2006. (Pubitemid 44916089)
55. J. Forbes, "The incidence of breast cancer: The global burden, public health considerations," Semin. Oncol., vol. 24, pp. S1-20-S1-35, 1997.
56. K. Kingsbury, "The changing face of breast cancer," in Time Mag. New York: Time Inc., 2007, vol. 170.
57. R. Smith, M. Caleffi, U. Albert, T. Chen, S. Duffy, D. Franceschi, and L. Nyström, "Panel GSEDaAtC. Breast cancer in limited-resource countries: Early detection and access to care," Breast J., pp. S16-S26, Jan.-Feb. 2006. (Pubitemid 43385271)
58. T. Wu and B. West, "Mammography stage of adoption and decision balance among Asian Indian and Filipino American women," Cancer Nurs., vol. 30, pp. 390-398, 2007. (Pubitemid 47417667)
59. M. Lund, O. Brawley, K. Ward, J. Young, S. Gabram, and J. Eley, "Parity and disparity in first course treatment of invasive breast cancer," Breast Cancer Res. Treat., Jun. 2007.
60. L. Wang, D. Li, Z. Fu, H. Li, W. Jiang, and D. Li, "Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population," BMC Cancer, vol. 10, p. 173, 2007.
61. F. Saleh and S. Abdeen, "Pathobiological features of breast tumours in the State of Kuwait: A comprehensive analysis," J. Carcinog., vol. 6, pp. 1-12, 2007.
62. K. Hahn, M. Bondy, M. Selvan, M. Lund, J. Liff, E. Flagg, L. Brinton, P. Porter, J. Eley, and R. Coates, "Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer," Amer. J. Epidemiol., vol. 166, pp. 1035-44, 2007. (Pubitemid 47574681)
63. R. Nanda, L. Schumm, S. Cummings, J. Fackenthal, L. Sveen, F. Ademuyiwa, M. Cobleigh, L. Esserman, N. Lindor, S. Neuhausen, and O. Olopade, "Genetic testing in an ethnically diverse cohort of high-risk women: A comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry," JAMA, vol. 294, pp. 1925-33, 2005. (Pubitemid 41464694)
64. A. Smigal, E. Ward, V. Cokkinides, R. Smith, H. Howe, and M. Thun, "Trends in breast cancer by race and ethnicity: Update 2006," CA Cancer J. Clin., vol. 56, 2006.
65. C. Li, K. Malone, and J. Daling, "Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older," Cancer Epidemiol. Biomarkers Prev., vol. 11, pp. 501-607, 2002.
66. X. Sim, R. Ali, S. Wedren, D. Goh, C. Tan, M. Reilly, P. Hall, and K. Chia, "Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968-2002," BMC Cancer, vol. 6, p. 261, 2006.
67. R. Yarden, E. Friedman, S. Metsuyanim, T. Olender, E. Ben-Asher, and M. Papa, "MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent," Breast Cancer Res. Treat., 2007.
68. S. Zackrisson, L. Janzon, J. Manjer, and I. Andersson, "Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999," J. Med. Screen, vol. 14, pp. 138-143, 2007. (Pubitemid 47511123)
69. B. Anderson, S. Braun, S. Lim, R. Smith, S. Taplin, and D. Thomas, "Panel. GSED. Early detection of breast cancer in countries with limited resources," Breast J., pp. S51-S59, May-Jun. 2003. (Pubitemid 36627147)
70. S. L. Kichun, M. F. Abouelnasr, C. W. Bayer, S. G. A. Gabram, B. Mizaikoff, and A. Rogatko, "Mining exhaled volatile organic compounds for breast cancer detection," Adv. Appl. Statist. Sci., vol. 2, no. 1, pp. 1-16, 2009.
71. C. Weisel and R. Yu, "Biomarkers of environmental benzene exposure," Environ. Health Perspectives Supplements, vol. 104, p. 1141, 1996.
72. L. A. Wallace, "Human exposure to volatile organic pollutants: Implications for Indoor Air Studies," Annu. Rev. Energy Environ., vol. 26, p. 269, 2001.
73. L. Wallace, "The TEAM studies," EPA Journal, vol. 19, p. 23, 1993, (Cover story).
74. L. Wallace, The Total Exposure Assessment Methodology (TEAM) Study: Summary and Analysis. Washington, DC: U.S. Environmental Protection Agency, 1987, vol. 1.
75. L. A. Wallace and E. d. Pellizzari, "Recent advances in measuring exhaled breath and estimating exposure and body burden for volatile," Environ. Health Perspectives Supplements, vol. 103, p. 95, 1995.
76. X. Xu and C. P.Weisel, "Dermal uptake of chloroform and haloketones during bathing," J. Exposure Anal. Environ. Epidemiology, vol. 15, pp. 289-296, 2005. (Pubitemid 41140902)
77. R. Delfino, H. Gong, W. Linn, Y. Hu, and E. Pellizzari, "Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air," J. Exposure Anal. Environ. Epidemiology, vol. 13, pp. 348-363, 2003. (Pubitemid 37310938)
78. L. C. A. Amorim and Z. L. Cardeal, "Breath air analysis and its use as a biomarker in biological monitoring of occupational and environmental exposure to chemical agents," J. Chromatography B, vol. 853, pp. 1-9, 2007. (Pubitemid 46891364)
79. L. C. A. Amorim, J. P. Carneiro, and Z. L. Cardeal, "An optimized method for determination of benzene in exhaled air by gas chromatog-raphy- mass spectrometry using solid phase microextraction as a sampling technique," J. Chromatography B, vol. 865, pp. 141-146, 2008.
80. M.-L. Chen, S.-H. Chen, B.-R. Guo, and I.-F. Mao, "Relationship between environmental exposure to toluene, xylene and ethylbenzene and the expired breath concentrations for gasoline service workers," J. Environ. Monitoring, vol. 4, pp. 562-566, 2002. (Pubitemid 34864588)
81. E. Pellizari, L. Wallace, and S. Gordon, "Elimination kinetcis of volatile organics in humans using breath measurements," J. Exposure Anal. Environ. Epidemiology, vol. 2, pp. 341-355, 1992.
82. E. Pellizzairi, R. Zweidinger, and L. Sheldon, "Breath Sampling," IARC Scient. Pub., vol. 109, pp. 228-236, 1993.
83. Y. Lin, S. R. Dueker, A. D. Jones, S. E. Ebeler, and A. J. Clifford, "Protocol for collection and HPLC analysis of volatile carbonyl compounds in breath," Clin. Chem., vol. 41, no. 7, pp. 1028-1032, 1995.
84. F. Di Francesco, R. Fuoco, M. G. Trivella, and A. Ceccarini, "Breath analysis: Trends in techniques and clinical applications," Microchemical J., vol. 79, no. 1-2, pp. 405-410, 2005. (Pubitemid 40126348)
85. M. Libardoni, P. T. Stevens, J. H. Waite, and R. Sacks, "Analysis of human breath samples with a multi-bed sorption trap and comprehensive two-dimensional gas chromatography (GC x GC)," J. Chromatography B, vol. 842, no. 1, pp. 13-21, 2006. (Pubitemid 44311087)
86. P. F. Wilson, C. G. Freeman, M. J. McEwan, D. B. Milligan, R. A. Allardyce, and G. M. Shaw, "In situ analysis of solvents on breath and blood: A selected ion flow tube mass spectrometric study," Rapid Commun. Mass Spectrometry, vol. 16, no. 5, pp. 427-432, 2002.
87. C. Turner, P. Spanel, and D. Smith, "A longitudinal study of ammonia, acetone and propanol in the exhaled breath of 30 subjects using selected ion flow tube mass spectrometry," SIFT-MS. Physiol. Meas., vol. 27, no. 4, pp. 321-37, Feb. 2006.
88. D. Smith, C. Turner, and P. Spanel, "Volatile metabolites in the exhaled breath of healthy volunteers: Their levels and distributions," J. Breath Res., vol. 1, no. 1, 2007a.
89. D. Smith and P. Spanel, "The challenge of breath analysis for clinical diagnosis and therapeutic monitoring," Analyst, vol. 132, pp. 390-396, 2007b. (Pubitemid 46683840)
90. A. Amann, G. Poupart, S. Telser, M. Ledochowski, A. Schmid, and S. Mechtcheriakov, "Applications of breath gas analysis in medicine," Int. J. Mass Spectrometry, vol. 239, no. 2-3, pp. 227-233, 2004.
91. F. B. Berthold Moser, E. Guenther, L. Matthias, R. Josef, and L. Philipp, "Mass spectrometric profile of exhaled breath-field study by PTR-MS," Respiratory Phys. Neurobiol., vol. 145, pp. 295-300, 2005.
92. G. R. Harrison, A. D. J. Critchley, C. A. Mayhew, and J. M. Thompson, "Real-time breath monitoring of propofol and its volatile metabolites during surgery using a novel mass spectrometric technique: A feasibility study," Br. J. Anaesth., vol. 91, no. 6, pp. 797-799, 2003.
93. M. Phillips, "Can the electronic nose really sniff out lung cancer," Amer. J. Respir. Crit. Care Med., vol. 172, no. 8, p. 1060, 2005.
94. C. Di Natale, A. Macagnano, E. Martinelli, R. Paolesse, G. D'Arcangelo, C. Roscioni, A. Finazzi-Agro, and A. D'Amico, "Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors," Biosens. Bioelectron., vol. 18, no. 10, pp. 1209-1218, 2003. (Pubitemid 36776581)
95. S. S. Kim et al., "Mid-infrared trace gas analysis with single-pass FT-IR hollow waveguide gas sensors," Appl. Spectrosc., vol. 63, no. 3, 2009.
96. J. Faist et al., "Quantum cascade laser," Science, vol. 264, no. 5158, pp. 553-556, 1994.
97. K. P. Petrov, R. F. Curl, and F. K. Tittel, "Compact laser difference-frequency spectrometer for multicomponent trace gas detection," Appl. Phys. B-Lasers Opt., vol. 66, no. 5, pp. 531-538, May 1998.
98. 2 measurement in human breath with a single IV-VI mid-infrared laser," Opt. Lett., vol. 27, no. 2, pp. 107-109, 2002.
99. J. Jeffers et al., "Real-time diode laser measurements of vapor-phase benzene," Anal. Chem., vol. 76, no. 2, pp. 424-432, 2004. (Pubitemid 38090782)
100. C. Young, S.-S. Kim, and B. Mizaikoff, "Quantum cascade laser based gas and liquid chemical sensors," in Lasers in Chemistry, M. Lackner, Ed. Weinheim: Wiley-VCH, 2008.
101. A. Matlis et al., "Low-threshold and high power lamda approximately 9.0 micron quantum cascade lasers operating at room temperature," Appl. Phys. Lett., vol. 77, no. 12, pp. 1741-1743, 2000.
102. A. Popov et al., "High power InAsSb/InAsSbP double heterostructure laser for continuous wave operation at 3.6 microns," Appl. Phys. Lett., vol. 68, no. 20, pp. 2790-2792, 1996. (Pubitemid 126684037)
103. D. E. Heard and J. Allan, Analytical Techniques for Atmospheric Measurement. Hoboken, NJ: Wiley-Blackwell, 2006.
104. C. Charlton et al., "Midinfrared sensors meet nanotechnology: Trace gas sensing with quantum cascade lasers inside photonic band-gap hollow waveguides," Appl. Phys. Lett., vol. 86, no. 19, pp. 194102/1-194102/3, 2005.
105. L. Hvozdara et al., "Laser spectroscopy in the gas phase using GaAs/ AlGaAs quantum cascade lasers," Appl. Opt., vol. 39, pp. 6926-6930, 2000.
106. C. Charlton et al., "Hollow waveguide gas sensing with room-temperature quantum cascade lasers," IEE Optoelectronics, vol. 150, pp. 306-309, 2003.
107. J. Faist et al., "Distributed feedback quantum cascade lasers," Appl. Phys. Lett., vol. 70, no. 20, pp. 2670-2672, 1997. (Pubitemid 127639899)
108. B. G. Lee et al., "Widely tunable single-mode quantum cascade laser source for mid-infrared spectroscopy," Appl. Phys. Lett., vol. 91, no. 23, 2007.
109. A. Muller, M. Beck, and J. Faist, "Electrically tunable, room-temperature quantum-cascade lasers," Appl. Phys. Lett., vol. 75, no. 11, pp. 1509-1511, 1999. (Pubitemid 129304360)
110. C. Young et al., "Wavelength selection for quantum cascade lasers by cavity length," Appl. Phys. Lette., vol. 94, pp. 0911091-3, 2009.
111. G. P. Luo et al., "Broadly wavelength-tunable external cavity mid-infrared quantum cascade lasers," IEEE J. Quantum Electron., vol. 38, pp. 486-494, 2002.
112. R. Maulini et al., "Broadband tuning of external cavity bound-to-continuum quantum-cascade lasers," Appl. Phys. Lett., vol. 84, no. 10, pp. 1659-1661, 2004.
113. R. Maulini et al., "External cavity quantum-cascade laser tunable from 8.2 to 10.4 micro m using a gain element with a heterogeneous cascade," Appl. Phys. Lett., vol. 88, no. 20, pp. 201113/1-201113/3, 2006.
114. G. Wysocki et al., "Widely tunable mode-hop free external cavity quantum cascade laser for high resolution spectroscopic applications," Appl. Phys. B: Lasers Opt., vol. 81, no. 6, pp. 769-777, 2005. (Pubitemid 41521350)
115. G. Wysocki et al., "Widely tunable mode-hop free external cavity quantum cascade lasers for high resolution spectroscopy and chemical sensing," Appl. Phys. B: Lasers Opt., vol. 92, no. 3, pp. 305-311, 2008.
116. C. Young et al., "External cavity widely tunable quantum cascade laser based hollow waveguide gas sensors for multianalyte detection," Sens. Actuators B, vol. 140, pp. 24-28, 2009.
117. J. A. Harrington, "A review of IR transmitting, hollow waveguides," Fiber Integr. Opt., vol. 19, no. 3, pp. 211-227, 2000.
118. J. D. Joannopoulos, R. Meade, and J. Winn, Photonic Crystals. Princeton, NJ: Princeton Univ. Press, 1995.
119. C. Young et al., "Optimizing gas sensors based on quantum cascade lasers and photonic bandgap hollow waveguides," in Proc. IEEE Sensors, Atlanta, GA, 2007, pp. 1345-1348.
120. A. G. Bell, "Upon the production of sound by radiant energy," Philosophical Mag., vol. 11, pp. 510-528.
121. A. Elia, P. M. Lugara, and C. Giancaspro, "Photoacoustic detection of nitric oxide by use of a quantum-cascade laser," Opt. Lett., vol. 30, no. 9, pp. 988-990, 2005. (Pubitemid 40749258)
122. M. B. Filho et al., "Ammonia detection by using quantum-cascade laser photoacoustic spectroscopy," Appl. Opt., vol. 45, no. 20, pp. 4966-4971, 2006.
123. A. Grossel et al., "Optimization of a compact photoacoustic quantum cascade laser spectrometer for atmospheric flux measurements: Application to the detection of methane and nitrous oxide," Appl. Phys. B: Lasers Opt., vol. 88, no. 3, pp. 483-492, 2007. (Pubitemid 47292970)
124. M. B. Pushkarsky et al., "High-sensitivity detection of TNT," in Proc Nat. Acad. Sci. USA, 2006, vol. 103, pp. 19630-19634, 52.
125. A. A. Kosterev, Y. A. Bakhirkin, and F. K. Tittel, "Ultrasensitive gas detection by quartz-enhanced photoacoustic spectroscopy in the fundamental molecular absorption bands region," Appl. Phys. B: Lasers Opt., vol. 80, no. 1, pp. 133-138, 2005.
126. C. Charlton et al., "Fabrication and characterization of molecular beam epitaxy grown thin-film GaAs waveguides for mid-infrared evanescent field chemical sensing," Anal. Chem., vol. 78, no. 12, pp. 4224-4227, 2006. (Pubitemid 43927419)
127. C. Charlton, A. Katzir, and B. Mizaikoff, "Infrared evanescent field sensing with quantum cascade lasers and planar silver halide waveguides," Anal. Chem., vol. 77, no. 14, pp. 4398-4403, 2005. (Pubitemid 41542259)
128. C. Roller et al., "Carbonyl sulfide detection with a thermoelectric ally cooled mid-infrared quantum cascade laser," Opt. Lett., vol. 28, no. 21, pp. 2052-2054, Nov. 2003.
129. M. R. McCurdy, Y. A. Bakhirkin, and F. K. Tittel, "Quantum cascade laser-based integrated cavity output spectroscopy of exhaled nitric oxide," Appl. Phys. B-Lasers Opt., vol. 85, no. 2-3, pp. 445-452, Nov. 2006.
130. K. Namjou, C. B. Roller, and P. J. McCann, "The breathmeter - A new laser device to analyze your health," IEEE Circuits Devices, vol. 22, no. 5, pp. 22-28, Sep.-Oct. 2006. (Pubitemid 46062866)
131. B. Mizaikoff, "Mid-infrared fiber-optic sensors," Anal. Chem., vol. 75, pp. 258A-267A, 2003.
132. S. S. Kim, C. Young, and B. Mizaikoff, "Miniaturized mid-infrared sensor technologies," Anal. Bioanal. Chem., vol. 390, no. 1, pp. 231-237, Jan. 2008.
133. M. Phillips et al., "Detection of lung cancer using weighted digital analysis of breath biomarkers," Clinica Chimica Acta., vol. 393, no. 2, pp. 76-84, Jul. 2008.
134. A. W. Dohlman, H. R. Black, and J. A. Royall, "Expired breath hydrogen-peroxide is a marker of acute airway inflammation in pediatric-patients with asthma," Amer. Rev. Respiratory Disease, vol. 148, no. 4, pp. 955-960, Oct. 1993.
135. Q. Jobsis et al., "Hydrogen peroxide in exhaled air of healthy children: Reference values," Eur. Respiratory J., vol. 12, no. 2, pp. 483-485, Aug. 1998. (Pubitemid 28389550)
136. A. Antczak et al., "Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients," Eur. Respiratory J., vol. 10, no. 6, pp. 1235-1241, Jun. 1997. (Pubitemid 27278239)
137. T. Hanazawa, S. A. Kharitonov, and P. J. Barnes, "Increased nitrotyrosine in exhaled breath condensate of patients with asthma," Amer. J. Respiratory Critical Care Med., vol. 162, no. 4, pp. 1273-1276, Oct. 2000.
138. P. Montuschi et al., "Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients," Amer. J. Respiratory Critical Care Med., vol. 160, no. 1, pp. 216-220, Jul. 1999. (Pubitemid 29326091)
139. D. Nowak et al., "Increased content of hydrogen peroxide in the expired breath of cigarette smokers," Eur. Respiratory J., vol. 9, no. 4, pp. 652-657, Apr. 1996. (Pubitemid 26167866)
140. D. Nowak et al., "Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: No significant effect of cigarette smoking," Respiratory Med., vol. 93, no. 6, pp. 389-396, Jun. 1999. (Pubitemid 29265348)
141. P. Montuschi et al., "Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers," Amer. J. Respiratory Critical Care Med., vol. 162, no. 3, pp. 1175-1177, Sep. 2000.
142. P. Montuschi et al., "8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases," Amer. J. Respiratory Critical Care Med., vol. 158, no. 5, pp. 1524-1527, Nov. 1998.
143. Y. Ishibe et al., "Exhaled nitric oxide level decreases after cardiopulmonary bypass in adult patients," Critical Care Med., vol. 28, no. 12, pp. 3823-3827, Dec. 2000. (Pubitemid 32044478)
144. S. J. Brett and T. W. Evans, "Measurement of endogenous nitric oxide in the lungs of patients with the acute respiratory distress syndrome," Amer. J. Respiratory Critical Care Med., vol. 157, no. 3, pp. 993-997, Mar. 1998.
145. S. R. Baldwin et al., "Oxidant activity in expired breath of patients with adult respiratory-distress syndrome," Lancet, vol. 1, no. 8471, pp. 11-14, Jan. 1986.
146. M. L. Simenhoff et al., "Biochemical profile of uremic breath," New England J. Med., vol. 297, no. 3, pp. 132-135, 1977.
147. L. R. Narasimhan, W. Goodman, and C. K. N. Patel, "Correlation of breath ammonia with blood urea nitrogen and creatinine during hemodialysis," in Proc. Nat. Acad. Sci. USA, Apr. 2001, vol. 98, pp. 4617-4621, 8.
148. S. S. Sehnert et al., "Breath biomarkers for detection of human liver diseases: Preliminary study," Biomarkers, vol. 7, no. 2, pp. 174-187, Mar.-Apr. 2002.
149. S. M. Studer et al., "Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection," J. Heart and Lung Transplantation, vol. 20, no. 11, pp. 1158-1166, Nov. 2001.
150. A. Canete et al., "13C-urea breath test with 50 mg of urea: An accurate method for the diagnosis of H. pylori infection in children," Gastroenterology, vol. 122, no. 4, p. S1327, Apr. 2002.
151. J. C. Atherton and R. C. Spiller, "The urea breath test for helicobacterpylori," Gut, vol. 35, no. 6, pp. 723-725, Jun. 1994.
152. F. Bazzoli, M. Zagari, and S. Fossi et al., "Urea breath tests for the detection of helicobacter pylori infection," Heliobacter, vol. 2, no. s1, pp. 34-37.
153. V. Savarino, S. Vigneri, and G. Celle, "The C-13 urea breath test in the diagnosis of Helicobacter pylori infection," GUT, vol. 45, pp. I18-I22, 1999. (Pubitemid 29297999)
154. D. Y. Graham and P. D. Klein, "Accurate diagnosis of Helicobacter pylori - C-13-urea breath test," Gastroenterology Clinics of North America, vol. 29, no. 4, p. 885, Dec. 2000.